Original language | English |
---|---|
Pages (from-to) | 1032-1035 |
Number of pages | 4 |
Journal | Blood |
Volume | 131 |
Issue number | 9 |
DOIs | |
State | Published - Mar 1 2018 |
Loss of Toll-like receptor 2 results in accelerated leukemogenesis in the NUP98-HOXD13 mouse model of MDS
Darlene A. Monlish, Sima T. Bhatt, Eric J. Duncavage, Zev J. Greenberg, John L. Keller, Molly P. Romine, Wei Yang, Peter D. Aplan, Matthew J. Walter, Laura G. Schuettpelz
- Institute of Clinical and Translational Sciences (ICTS)
- Siteman Cancer Center
- Division of Anatomic and Molecular Pathology (AMP)
- Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
- Center of Regenerative Medicine
- Division of Hematology & Oncology
- Bursky Center for Human Immunology & Immunotherapy Programs (CHiiPs)
- Section of Stem Cell Biology
- DBBS - Molecular Genetics and Genomics
- DBBS - Cancer Biology
- DBBS - Developmental, Regenerative and Stem Cell Biology
- DBBS - Immunology
Research output: Contribution to journal › Letter › peer-review
12
Scopus
citations